News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
McNeill Jonathan
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
03/15/2023 |
4
| McNeill Jonathan (See Remarks) has filed a Form 4 on Dyne Therapeutics, Inc.
Txns:
| Sold 1,000 shares
@ $13, valued at
$13k
Sold 1,209 shares
@ $13.33, valued at
$16.1k
|
|
01/23/2023 |
4
| McNeill Jonathan (See Remarks) has filed a Form 4 on Dyne Therapeutics, Inc.
Txns:
| Sold 10,000 shares
@ $14.03, valued at
$140.3k
Exercised 10,000 options to buy
@ $0.73, valued at
$7.3k
|
|
01/11/2023 |
4
| McNeill Jonathan (See Remarks) has filed a Form 4 on Dyne Therapeutics, Inc.
Txns:
| Sold 30,150 shares
@ $11.57, valued at
$348.8k
|
|
12/13/2022 |
4
| McNeill Jonathan (See Remarks) has filed a Form 4 on Dyne Therapeutics, Inc.
Txns:
| Granted 40,000 shares
@ $0 Sold 472 shares
@ $10.87, valued at
$5.1k
Granted 63,000 options to buy
@ $10.72, valued at
$675.4k
|
|
09/21/2022 |
4
| McNeill Jonathan (See Remarks) has filed a Form 4 on Dyne Therapeutics, Inc.
Txns:
| Disposed/sold 1,246 shares
@ $13.7, valued at
$17.1k
|
|
09/15/2022 |
4
| McNeill Jonathan (See Remarks) has filed a Form 4 on Dyne Therapeutics, Inc.
Txns:
| Disposed/sold 494 shares
@ $14.05, valued at
$6.9k
|
|
07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/18/2020 |
4
| McNeill Jonathan (See Remarks) has filed a Form 4 on Dyne Therapeutics, Inc.
Txns:
| Granted 17,012 shares
@ $0 Granted 52,787 options to buy
@ $19, valued at
$1M
|
|
09/16/2020 |
3
| McNeill Jonathan (See Remarks) has filed a Form 3 on Dyne Therapeutics, Inc. |
|
|